VISEN Pharmaceuticals (HKG:2561)

VISEN Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	805.91	203.59	347.78	626.46
Cash & Short-Term Investments	805.91	203.59	347.78	626.46
Cash Growth	131.73%	-41.46%	-44.48%	-
Other Receivables	2.47	1.77	4.09	1.45
Receivables	2.47	1.77	4.09	1.45
Other Current Assets	60.88	17.22	22.25	83.69
Total Current Assets	869.25	222.57	374.12	711.59
Property, Plant & Equipment	1.31	11.16	13.26	17.16
Other Intangible Assets	0.03	0.05	0.57	1.42
Other Long-Term Assets	22.77	60.04	55.85	11.1
Total Assets	893.36	293.82	443.8	741.27
Accounts Payable	2.82	11.12	1.01	27.98
Accrued Expenses	29.44	22.54	29.85	25.48
Current Portion of Leases	1.2	2	2.55	4.67
Current Income Taxes Payable	0.65	2.67	1.85	2.57
Current Unearned Revenue	-	-	2.9	2.9
Other Current Liabilities	3.7	13.87	13.67	23.74
Total Current Liabilities	37.81	52.19	51.82	87.34
Long-Term Leases	-	0.36	1.1	1.33
Total Liabilities	37.81	52.55	52.92	88.67
Common Stock	0.08	0.07	0.07	0.07
Additional Paid-In Capital	2,221	1,523	1,523	1,523
Retained Earnings	-1,732	-1,614	-1,431	-1,182
Treasury Stock	-0.01	-0.01	-0.01	-0.01
Comprehensive Income & Other	365.99	331.55	298.91	311.07
Shareholders' Equity	855.55	241.28	390.88	652.61
Total Liabilities & Equity	893.36	293.82	443.8	741.27
Total Debt	1.2	2.36	3.65	6
Net Cash (Debt)	804.71	201.23	344.13	620.46
Net Cash Growth	133.84%	-41.53%	-44.54%	-
Net Cash Per Share	8.31	2.15	3.68	-
Filing Date Shares Outstanding	105.02	9.34	9.34	-
Total Common Shares Outstanding	105.02	9.34	9.34	-
Working Capital	831.45	170.39	322.3	624.25
Book Value Per Share	8.15	25.83	41.85	-
Tangible Book Value	855.53	241.22	390.31	651.19
Tangible Book Value Per Share	8.15	25.83	41.79	-
Machinery	-	1.56	1.53	1.59
Leasehold Improvements	-	0.28	1.76	3.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.